Baxter International | BAX - Ativos

Preço das Ações
17.58
Mudança Diária
0.68 4.02%
Mensal
4.64%
Anual
-42.68%
Q2 Previsão
17.77




Ativos Alterar Data
Abbott USD 110.43B 23.72B 2026-03
AngioDynamics USD 269.68M 4.04M 2025-09
Artivion USD 884.8M 27.13M 2025-12
AtriCure USD 654.18M 18.74M 2025-12
Avanos Medical USD 1.07B 6M 2025-12
Baxter International USD 19.85B 209M 2026-03
Becton, Dickinson and Co. USD 54.84B 484M 2025-12
Boston Scientific USD 43.67B 966M 2025-12
Cooper Companies USD 12.42B 29.4M 2025-12
Dexcom USD 6.63B 293.4M 2026-03
Edwards Lifesciences USD 13.7B 425M 2025-12
Fresenius EUR 42.46B 1.14B 2025-09
Globus Medical USD 5.3B 207.12M 2025-12
Halozyme Therapeutics USD 2.53B 304.09M 2025-12
ICU Medical USD 4.05B 52.39M 2025-12
Inogen USD 307.01M 5.03M 2025-09
Insulet USD 3.19B 161.1M 2025-12
Integra LifeSciences USD 3.6B 44.45M 2025-12
Intuitive Surgical USD 20.11B 347.7M 2026-03
J&J USD 200.89B 1.68B 2026-03
Laboratory Of America USD 18.39B 131.1M 2025-12
Masimo USD 1.7B 118.6M 2025-12
Medtronic USD 91.48B 139M 2025-12
Merit Medical Systems USD 2.72B 33.36M 2026-03
Quest Diagnostics USD 16.67B 448M 2026-03
Smith & Nephew USD 10.69B 150M 2025-12
Stryker USD 47.84B 787M 2025-12
Tandem Diabetes Care USD 881.11M 6.46M 2025-12
Teleflex USD 6.95B 924.7M 2025-12
Terumo JPY 2.26T 362.12B 2025-12
Zimmer Biomet Holdings USD 22.72B 370.1M 2026-03